Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-055433

Chief Operating Officer acquired 218 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Radovich Peter Chief Operating Officer 2023-11-10 Grant or award +218 $22.29 $4,859 37,893 D
Loading xslF345X05/doc4.xml…